References 1. Kintz, P; Samyn, N. Use of alternative specimens: drugs of abuse in saliva and doping agents in hair. Ther Drug Monit. 2002;24:239–46. [PubMed]2. Marquet, P. Progress of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Ther Drug Monit. 2002;24:255–76. [PubMed]3. Maurer, HH. Liquid chromatography-mass spectrometry in forensic and clinical toxicology. J Chromatogr B Biomed Sci Appl. 1998;713:3–25. [PubMed]4. Van Bocxlaer, JF; Clauwaert, KM; Lambert, WE; Deforce, DL; Van den Eeckhout, EG; De Leenheer, AP. Liquid chromatography-mass spectrometry in forensic toxicology. Mass Spectrom Rev. 2000;19:165–214. [PubMed]5. Choo, RE; Huestis, MA. Oral fluid as a diagnostic tool. Clin Chem Lab Med. 2004;42:1273–87. [PubMed]6. Caplan, YH; Goldberger, BA. Alternative specimens for workplace drug testing. J Anal Toxicol. 2001;25:396–9. [PubMed]7. Walsh, JM; de Gier, JJ; Christopherson, AS; Verstraete, AG. Drugs and driving. Traffic Inj Prev. 2004;5:241–53. [PubMed]8. Kadehjian, L. Legal issues in oral fluid testing. Forensic Sci Int. 2005;150:151–60. [PubMed]9. Verstraete, AG. Detection times of drugs of abuse in blood, urine, and oral fluid. Ther Drug Monit. 2004;26:200–5. [PubMed]10. Drummer, OH. Review: Pharmacokinetics of illicit drugs in oral fluid. Forensic Sci Int. 2005;150:133–42. [PubMed]11. Aps, JK; Martens, LC. Review: The physiology of saliva and transfer of drugs into saliva. Forensic Sci Int. 2005;150:119–31. [PubMed]12. O'Neal, CL; Crouch, DJ; Rollins, DE; Fatah, AA. The effects of collection methods on oral fluid codeine concentrations. J Anal Toxicol. 2000;24:536–42. [PubMed]13. Crouch, DJ. Oral fluid collection: the neglected variable in oral fluid testing. Forensic Sci Int. 2005;150:165–73. [PubMed]14. Schepers, RJ; Oyler, JM; Joseph, RE, Jr; Cone, EJ; Moolchan, ET; Huestis, MA. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem. 2003;49:121–32. [PubMed]15. Kato, K; Hillsgrove, M; Weinhold, L; Gorelick, DA; Darwin, WD; Cone, EJ. Cocaine and metabolite excretion in saliva under stimulated and nonstimulated conditions. J Anal Toxicol. 1993;17:338–41. [PubMed]16. Wong, RC; Tran, M; Tung, JK. Oral fluid drug tests: effects of adulterants and foodstuffs. Forensic Sci Int. 2005;150:175–80. [PubMed]17. Maseda, C; Hama, K; Fukui, Y; Matsubara, K; Takahashi, S; Akane, A. Detection of delta 9-THC in saliva by capillary GC/ECD after marihuana smoking. Forensic Sci Int. 1986;32:259–66. [PubMed]18. Chu, M; Wells, DL; King, RG; Farrar, J; Drummer, OH. The effect of blood in the oral cavity on breath alcohol analysis. J Clin Forensic Med. 1998;5:114–8. [PubMed]19. Teixeira, H; Proenca, P; Verstraete, A; Corte-Real, F; Vieira, DN. Analysis of Delta9-tetrahydrocannabinol in oral fluid samples using solid-phase extraction and high-performance liquid chromatography-electrospray ionization mass spectrometry. Forensic Sci Int. 2005;150:205–11. [PubMed]20. Dickson SJ, Park A, Nolan SL, et al. The recovery of drugs from oral fluid collection devices. Forensic Sci Int 2006;In Press. 21. Moore C, Vincent M, Rana S, Coulter C, Agrawal A, Soares J. Stability of Delta(9)-tetrahydrocannabinol (THC) in oral fluid using the Quantisal(TM) collection device. Forensic Sci Int Epub 2006 Jan 16 ahead of print. 22. Verstraete, AG. Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges. Forensic Sci Int. 2005;150:143– 50. [PubMed]23. Verstraete, AG; Pierce, A. Workplace drug testing in Europe. Forensic Sci Int. 2001;121:2–6. [PubMed]24. George, S. A snapshot of workplace drug testing in the UK. Occup Med (Lond). 2005;55:69–71. [PubMed]25. Cone EJ, Jenkins AJ. Saliva Drug Analysis. In: Wong SHY, Sunshine I, eds. Handbook of Analytical Therapeutic Drug Monitoring and Toxicology. Roca Baton, Florida: CRC Press, 1997, pp303–33. 26. Cone, EJ; Hillsgrove, M; Darwin, WD. Simultaneous measurement of cocaine, cocaethylene, their metabolites, and "crack" pyrolysis products by gas chromatographymass spectrometry. Clin Chem. 1994;40:1299–305. [PubMed]27. Jenkins, AJ; Oyler, JM; Cone, EJ. Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma. J Anal Toxicol. 1995;19:359–74. [PubMed]28. Guidelines for testing drugs under international control in hair, sweat and saliva. Vienna, Austria: United Nations, 1998. 29. Jones, AW. Inter- and intra-individual variations in the saliva/blood alcohol ratio during ethanol metabolism in man. Clin Chem. 1979;25:1394–8. [PubMed]30. Haeckel, R; Peiffer, U. Comparison of ethanol concentration in saliva and blood from police controlled Clin Biochem Rev Vol 27 August 2006 I 155 Oral Fluid Drugs persons. Blutalkohol. 1992;29:342–9. [PubMed]31. Jones, AW. Measuring ethanol in saliva with the QED enzymatic test device: comparison of results with blood- and breath-alcohol concentrations. J Anal Toxicol. 1995;19:169–74. [PubMed]32. Menkes, DB; Howard, RC; Spears, GF; Cairns, ER. Salivary THC following cannabis smoking correlates with subjective intoxication and heart rate. Psychopharmacology (Berl). 1991;103:277–9. [PubMed]33. Huestis, MA; Cone, EJ. Relationship of delta-9- tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. J Anal Toxicol. 2004;28:394–9. [PubMed]34. O'Neal, CL; Crouch, DJ; Rollins, DE; Fatah, A; Cheever, ML. Correlation of saliva codeine concentrations with plasma concentrations after oral codeine administration. J Anal Toxicol. 1999;23:452–9. [PubMed]35. Kim, I; Barnes, AJ; Oyler, JM, et al. Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration. Clin Chem. 2002;48:1486–96. [PubMed]36. Mendelson, J; Upton, RA; Everhart, ET; Jacob, P, 3rd; Jones, RT. Bioavailability of sublingual buprenorphine. J Clin Pharmacol. 1997;37:31–7. [PubMed]37. Nath, RP; Upton, RA; Everhart, ET, et al. Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations. J Clin Pharmacol. 1999;39:619–23. [PubMed]38. Cone, EJ; Dickerson, SL; Darwin, WD; Fudala, P; Johnson, RE. Elevated drug saliva levels suggest a "depot-like" effect in subjects treated with sublingual buprenorphine. NIDA Res Monogr. 1990;105:569. [PubMed]39. Curvall, M; Elwin, CE; Kazemi-Vala, E; Warholm, C; Enzell, CR. The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers. Eur J Clin Pharmacol. 1990;38:281–7. [PubMed]40. Curvall, M; Vala, EK; Enzell, CR; Wahren, J. Simulation and evaluation of nicotine intake during passive smoking: cotinine measurements in body fluids of nonsmokers given intravenous infusions of nicotine. Clin Pharmacol Ther. 1990;47:42–9. [PubMed]41. Giles, HG; Miller, R; Macleod, SM; Sellers, EM. Diazepam and N-desmethyldiazepam in saliva of hospital inpatients. J Clin Pharmacol. 1980;20:71–6. [PubMed]42. DiGregorio, GJ; Piraino, AJ; Ruch, E. Diazepam concentrations in parotid saliva, mixed saliva, and plasma. Clin Pharmacol Ther. 1978;24:720–5. [PubMed]43. de Gier, JJ; 't Hart, BJ; Nelemans, FA; Bergman, H. Psychomotor performance and real driving performance of outpatients receiving diazepam. Psychopharmacology (Berl). 1981;73:340–4. [PubMed]44. Concheiro, M; Villain, M; Bouchet, S; Ludes, B; Lopez- Rivadulla, M; Kintz, P. Windows of detection of tetrazepam in urine, oral fluid, beard, and hair, with a special focus on drug-facilitated crimes. Ther Drug Monit. 2005;27:565–70. [PubMed]45. Samyn, N; De Boeck, G; Cirimele, V; Verstraete, A; Kintz, P. Detection of flunitrazepam and 7- aminoflunitrazepam in oral fluid after controlled administration of rohypnol. J Anal Toxicol. 2002;26:211–5. [PubMed]46. Hart, BJ; Wilting, J; de Gier, JJ. The stability of benzodiazepines in saliva. Methods Find Exp Clin Pharmacol. 1988;10:21–6. [PubMed]47. Ritschel, WA; Parab, PV; Denson, DD; Coyle, DE; Gregg, RV. Absolute bioavailability of hydromorphone after peroral and rectal administration in humans: saliva/plasma ratio and clinical effects. J Clin Pharmacol. 1987;27:647–53. [PubMed]48. Matin, SB; Wan, SH; Knight, JB. Quantitative determination of enantiomeric compounds. I-- Simultaneous measurement of the optical isomers of amphetamine in human plasma and saliva using chemical ionization mass spectrometry. Biomed Mass Spectrom. 1977;4:118–21. [PubMed]49. Chen, ZR; Bochner, F; Somogyi, A. Pharmacokinetics of pholcodine in healthy volunteers: single and chronic dosing studies. Br J Clin Pharmacol. 1988;26:445–53. [PubMed]50. Tracqui, A; Ludes, B. HPLC-MS for the determination of sildenafil citrate (Viagra) in biological fluid s. Application to the salivary excretion of sildenafil after oral intake. J Anal Toxicol. 2003;27:88–94. [PubMed]51. Drobitch, RK; Svensson, CK. Therapeutic drug monitoring in saliva. An update. Clin Pharmacokinet. 1992;23:365–79. [PubMed]52. Liu, H; Delgado, MR. Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants. Clin Pharmacokinet. 1999;36:453–70. [PubMed]53. Vasudev, A; Tripathi, KD; Puri, V. Correlation of serum and salivary carbamazepine concentration in epileptic patients: implications for therapeutic drug monitoring. Neurol India. 2002;50:60–2. [PubMed]54. Miles, MV; Tang, PH; Glauser, TA, et al. Topiramate concentration in saliva: an alternative to serum monitoring. Pediatr Neurol. 2003;29:143–7. [PubMed]55. Moolchan, ET; Umbricht, A; Epstein, D. Therapeutic drug monitoring in methadone maintenance: choosing a matrix. J Addict Dis. 2001;20:55–73. [PubMed]56. Sagawa, K; Mohri, K; Shimada, S; Shimizu, M; Muramatsu, J. Disopyramide concentrations in human plasma and saliva: comparison of disopyramide concentrations in saliva and plasma unbound concentrations. Eur J Clin Pharmacol. 1997;52:65–9. [PubMed]57. Mortier KA, Renard V, Verstraete AG, Van Gussem A, Van Belle S, Lambert WE. Development and validation of a liquid chromatography-tandem mass spectrometry assay for the quantification of docetaxel and paclitaxel in human plasma and oral fluid. Anal Chem 2005;77:4677–83. 156 I Clin Biochem Rev Vol 27 August 2006 Drummer O. 58. Spielberg, F; Critchlow, C; Vittinghoff, E, et al. Home collection for frequent HIV testing: acceptability of oral fluid s, dried blood spots and telephone results. HIV Early Detection Study Group. AIDS. 2000;14:1819–28. [PubMed]59. Soldin, SJ; Rakhmanina, NY; Spiegel, HM; Sever, JL. Therapeutic drug monitoring for patients with HIV infection: Children's National Medical Center, Washington DC experience. Ther Drug Monit. 2004;26:107–9. [PubMed]60. Gallagher P, Leitch MM, Massey AE, McAllister Williams RH, Young AH. Assessing cortisol and dehydroepiandrosterone (DHEA) in saliva: effects of collection method. J Psychopharmacol 2006 Jan 9 ahead of print. Jan 9;[Epub ahead of print]. 61. Mylonas, PG; Makri, M; Georgopoulos, NA, et al. Adequacy of saliva 17-hydroxyprogesterone determination using various collection methods. Steroids. 2006;71:273–6. [PubMed]62. Kintz, P; Cirimele, V; Ludes, B. Codeine testing in sweat and saliva with the Drugwipe. Int J Legal Med. 1998;111:82–4. [PubMed]63. Samyn, N; van Haeren, C. On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users. Int J Legal Med. 2000;113:150–4. [PubMed]64. Grönholm, M; Lillsunde, P. A comparison between onsite immunoassay drug-testing devices and laboratory results. Forensic Sci Int. 2001;121:37–46. [PubMed]65. Kolbrich, EA; Kim, I; Barnes, AJ, et al. Cozart RapiScan Oral Fluid Drug Testing System: an evaluation of sensitivity, specificity, and efficiency for cocaine detection compared with ELISA and GC-MS following controlled cocaine administration. J Anal Toxicol. 2003;27:407–11. [PubMed]66. Samyn, N; De Boeck, G; Verstraete, AG. The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers. J Forensic Sci. 2002;47:1380–7. [PubMed]67. Pichini, S; Navarro, M; Farre, M, et al. On-site testing of 3,4-methylenedioxymethamphetamine (ecstasy) in saliva with Drugwipe and Drugread: a controlled study in recreational users. Clin Chem. 2002;48:174–6. [PubMed]68. Laloup, M; Tilman, G; Maes, V, et al. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid. Forensic Sci Int. 2005;153:29–37. [PubMed]69. Kupiec, T; DeCicco, L; Spiehler, V; Sneed, G; Kemp, P. Choice of an ELISA assay for screening postmortem blood for amphetamine and/or methamphetamine. J Anal Toxicol. 2002;26:513–8. [PubMed]70. De Giovanni, N; Fucci, N; Scarlata, S; Donzelli, G. Buprenorphine detection in biological samples. Clin Chem Lab Med. 2005;43:1377–9. [PubMed]71. Kim, I; Barnes, AJ; Schepers, R, et al. Sensitivity and specificity of the Cozart microplate EIA cocaine oral fluid at proposed screening and confirmation cutoffs. Clin Chem. 2003;49:1498–503. [PubMed]72. Lachenmeier, K; Musshoff, F; Madea, B. Determination of opiates and cocaine in hair using automated enzyme immunoassay screening methodologies followed by gas chromatographic-mass spectrometric (GC-MS) confirmation. Forensic Sci Int. 2006;159:189–99. [PubMed]73. Cooper, G; Wilson, L; Reid, C; Baldwin, D; Hand, C; Spieher, V. Validation of the Cozart microplate EIA for cocaine and metabolites in oral fluid. J Anal Toxicol. 2004;28:498–503. [PubMed]74. Cooper, G; Wilson, L; Reid, C; Baldwin, D; Hand, C; Spiehler, V. Comparison of GC-MS and EIA results for the analysis of methadone in oral fluid. J Forensic Sci. 2005;50:928–32. [PubMed]75. Kacinko, SL; Barnes, AJ; Kim, I, et al. Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration. Forensic Sci Int. 2004;141:41–8. [PubMed]76. Barnes, AJ; Kim, I; Schepers, R, et al. Sensitivity, specificity, and efficiency in detecting opiates in oral fluid with the Cozart Opiate Microplate EIA and GCMS following controlled codeine administration. J Anal Toxicol. 2003;27:402–7. [PubMed]77. Niedbala, RS; Kardos, KW; Fritch, DF, et al. Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. J Anal Toxicol. 2001;25:289–303. [PubMed]78. Kemp, P; Sneed, G; Kupiec, T; Spiehler, V. Validation of a microtiter plate ELISA for screening of postmortem blood for opiates and benzodiazepines. J Anal Toxicol. 2002;26:504–12. [PubMed]79. Allen, KR; Azad, R; Field, HP; Blake, DK. Replacement of immunoassay by LC tandem mass spectrometry for the routine measurement of drugs of abuse in oral fluid. Ann Clin Biochem. 2005;42:277–84. [PubMed]80. Gunnar, T; Ariniemi, K; Lillsunde, P. Validated toxicological determination of 30 drugs of abuse as optimized derivatives in oral fluid by long column fast gas chromatography/electron impact mass spectrometry. J Mass Spectrom. 2005;40:739–53. [PubMed]81. Wylie, FM; Torrance, H; Anderson, RA; Oliver, JS. Drugs in oral fluid Part I. Validation of an analytical procedure for licit and illicit drugs in oral fluid. Forensic Sci Int. 2005;150:191–8. [PubMed]82. Mortier, KA; Maudens, KE; Lambert, WE, et al. Simultaneous, quantitative determination of opiates, amphetamines, cocaine and benzoylecgonine in oral fluid by liquid chromatography quadrupole-timeof- flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;779:321–30. 83. Wood, M; Laloup, M; Ramirez Fernandez Mdel, M, et al. Quantitative analysis of multiple illicit drugs in preserved oral fluid by solid-phase extraction and liquid Clin Biochem Rev Vol 27 August 2006 I 157 Oral Fluid Drugs chromatography-tandem mass spectrometry. Forensic Sci Int. 2005;150:227–38. [PubMed]84. Dams, R; Murphy, CM; Choo, RE; Lambert, WE; De Leenheer, AP; Huestis, MA. LC-atmospheric pressure chemical ionization-MS/MS analysis of multiple illicit drugs, methadone, and their metabolites in oral fluid following protein precipitation. Anal Chem. 2003;75:798–804. [PubMed]85. Draft Standard: Procedures for the collection, detection and quantitation of drugs in oral fluid. Standards Australia, 2006. 86. Niedbala, R; Kardos, K; Salamone, S; Fritch, D; Bronsgeest, M; Cone, EJ. Passive cannabis smoke exposure and oral fluid testing. J Anal Toxicol. 2004;28:546–52. [PubMed]87. Rohrig, TP; Moore, C. The determination of morphine in urine and oral fluid following ingestion of poppy seeds. J Anal Toxicol. 2003;27:449–52. [PubMed]88. Maurer, HH. Advances in analytical toxicology: the current role of liquid chromatography-mass spectrometry in drug quantification in blood and oral fluid. Anal Bioanal Chem. 2005;381:110–8. [PubMed]89. National Association of Testing Authorities, see www.nata.asn.au (accessed March 27, 2006). 90. de la Torre R, Segura J, de Zeeuw R, Williams J. Recommendations for the reliable detection of illicit drugs in urine in the European Union, with special attention to the workplace. EU Toxicology Experts working Group. Ann Clin Biochem 1997;34:339–44.. 91. Peters, FT; Maurer, HH. Bioanalytical method validation and its implications for forensic and clinical toxicology - A review. Accred Qual. Assur. 2002;7:441–9. 92. Clarke, J; Wilson, JF. Proficiency testing (external quality assessment) of drug detection in oral fluid. Forensic Sci Int. 2005;150:161–4. [PubMed]93. Walsh, JM; Flegel, R; Crouch, DJ; Cangianelli, L; Baudys, J. An evaluation of rapid point-of-collection oral fluid drug-testing devices. J Anal Toxicol. 2003;27:429–39. [PubMed]94. Crouch, DJ; Walsh, JM; Flegel, R; Cangianelli, L; Baudys, J; Atkins, R. An evaluation of selected oral fluid point-of- collection drug-testing devices. J Anal Toxicol. 2005;29:244–8. [PubMed]95. Cooper, G; Wilson, L; Reid, C; Main, L; Hand, C. Evaluation of the Cozart((R)) RapiScan drug test system for opiates and cocaine in oral fluid. Forensic Sci Int. 2005;150:239– 43. [PubMed]96. Moore, L; Wicks, J; Spiehler, V; Holgate, R. Gas chromatography-mass spectrometry confirmation of Cozart RapiScan saliva methadone and opiates tests. J Anal Toxicol. 2001;25:520–4. [PubMed]97. Toennes, SW; Kauert, GF; Steinmeyer, S; Moeller, MR. Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms. Forensic Sci Int. 2005;152:149–55. [PubMed]98. Kintz, P; Bernhard, W; Villain, M; Gasser, M; Aebi, B; Cirimele, V. Detection of cannabis use in drivers with the drugwipe device and by GC-MS after Intercept device collection. J Anal Toxicol. 2005;29:724–7. [PubMed]99. Cone, EJ; Presley, L; Lehrer, M, et al. Oral fluid testing for drugs of abuse: positive prevalence rates by Intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations. J Anal Toxicol. 2002;26:541–6. [PubMed]100. Kintz, P; Villain, M; Concheiro, M; Cirimele, V. Screening and confirmatory method for benzodiazepines and hypnotics in oral fluid by LC-MS/MS. Forensic Sci Int. 2005;150:213–20. [PubMed]101. Barrett, C; Good, C; Moore, C. Comparison of point-of- collection screening of drugs of abuse in oral fluid with a laboratory-based urine screen. Forensic Sci Int. 2001;122:163–6. [PubMed]102. Cirimele V, Villain M, Mura P, Bernard M, Kintz P. Oral fluid testing for cannabis: On-site Oraline(R) IV s.a.t. device versus GC/MS. Forensic Sci Int 2006; July 17; [Epub ahead of print]. 103. Lamey, PJ; Nolan, A. The recovery of human saliva using the Salivette system. Eur J Clin Chem Clin Biochem. 1994;32:727–8. [PubMed]104. Biermann, T; Schwarze, B; Zedler, B; Betz, P. On-site testing of illicit drugs: the use of the drug-testing device "Toxiquick". Forensic Sci Int. 2004;143:21–5. [PubMed]105. Cone, EJ. Saliva testing for drugs of abuse. Ann N Y Acad Sci. 1993;694:91–127. [PubMed]106. Inaba, T; Kalow, W. Salivary excretion of amobarbital in man. Clin Pharmacol Ther. 1975;18:558–62. [PubMed]107. van der Graaff, M; Vermeulen, NP; Heij, P; Boeijinga, JK; Breimer, DD. Pharmacokinetics of orally administered hexobarbital in plasma and saliva of healthy subjects. Biopharm Drug Dispos. 1986;7:265–72. [PubMed]108. Navarro, M; Pichini, S; Farre, M, et al. Usefulness of saliva for measurement of 3,4-methylenedioxymetham phetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pH. Clin Chem. 2001;47:1788–95. [PubMed]109. Chikhi-Chor, N; Pham-Huy, C; Galons, H, et al. Rapid determination of methadone and its major metabolite in biological fluid s by gas-liquid chromatography with thermionic detection for maintenance treatment of opiate addicts. J Chromatogr B Biomed Sci Appl. 1998;718:278–84. [PubMed]110. Kankaanpaa A, Gunnar T, Ariniemi K, Lillsunde P, Mykkanen S, Seppala T. Single-step procedure for gas chromatography-mass spectrometry screening and quantitative determination of amphetamine-type stimulants and related drugs in blood, serum, oral fluid and urine samples. J Chromatogr B Analyt Technol Biomed Life Sci 2004;810:57–68. 158 I Clin Biochem Rev Vol 27 August 2006 Drummer O. 111. Wood, M; De Boeck, G; Samyn, N, et al. Development of a rapid and sensitive method for the quantitation of amphetamines in human plasma and oral fluid by LCMS- MS. J Anal Toxicol. 2003;27:78–87. [PubMed]112. Quintela, O; Cruz, A; Castro, A; Concheiro, M; Lopez- Rivadulla, M. Liquid chromatography-electrospray ionisation mass spectrometry for the determination of nine selected benzodiazepines in human plasma and oral fluid. Journal of Chromatography B Analyt Technol Biomed Life Sci. 2005;825:63–71. |